Cargando…

Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study

BACKGROUND AND AIM: The COVID‐19 booster dose has been cited as an important supplement for the control of the COVID‐19 pandemic due to reports of waning immunity among fully vaccinated persons. Determining factors that would affect its acceptability is necessary for initiating successful vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Storph, Rebecca Peniel, Essuman, Mainprice Akuoko, Duku‐Takyi, Ruth, Akotua, Albert, Asante, Samuel, Armah, Richard, Donkoh, Irene Esi, Addo, Prince Anim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090037/
https://www.ncbi.nlm.nih.gov/pubmed/37064312
http://dx.doi.org/10.1002/hsr2.1203
_version_ 1785022883722952704
author Storph, Rebecca Peniel
Essuman, Mainprice Akuoko
Duku‐Takyi, Ruth
Akotua, Albert
Asante, Samuel
Armah, Richard
Donkoh, Irene Esi
Addo, Prince Anim
author_facet Storph, Rebecca Peniel
Essuman, Mainprice Akuoko
Duku‐Takyi, Ruth
Akotua, Albert
Asante, Samuel
Armah, Richard
Donkoh, Irene Esi
Addo, Prince Anim
author_sort Storph, Rebecca Peniel
collection PubMed
description BACKGROUND AND AIM: The COVID‐19 booster dose has been cited as an important supplement for the control of the COVID‐19 pandemic due to reports of waning immunity among fully vaccinated persons. Determining factors that would affect its acceptability is necessary for initiating successful vaccination programs. In this study, we aimed to evaluate the factors associated with the acceptability of the COVID‐19 booster dose in Ghana. METHODS: We conducted an online cross‐sectional survey among the public. A self‐administered questionnaire was used to collect information on demographic characteristics, willingness to vaccinate, perceptions toward COVID‐19 vaccines, and trust in the government. Participants provided reasons and sources of advice that may affect their willingness to accept a booster dose. Using IBM SPSS and R Statistic; descriptive, univariate, and multivariate analyses were performed. RESULTS: Out of 812 respondents, 375 (46.2%) intended to accept the booster dose. Individuals who were males (adjusted odds ratio [aOR] 1.63, 95% confidence interval [CI] 1.07−2.48), had previously received other forms of vaccination twice (aOR 1.96, 95% CI 1.07−3.57) or in most years (aOR 2.51, 95% CI 1.38−4.57), tested positive for COVID‐19 (aOR 3.46, 95% CI 1.23−10.52), have high trust in government (aOR=1.77, 95% CI: 1.15‐2.74) and had positive perceptions regarding COVID‐19 vaccines (OR = 14.24, 95% CI: 9.28−22.44) were more likely to accept a booster dose. Experiencing side effects from the primer dose (aOR 0.12, 95% CI 0.08−0.18) was associated with reduced acceptance. Concerns about vaccine safety and efficacy were the common reasons impeding willingness, while advice from health professionals would be the most considered. CONCLUSION: Low intention to accept the booster dose which is associated with a range of factors including the perception of vaccines and trust in the government, is a cause for concern. Thus, more effort would have to be taken through education and policy interventions to increase booster vaccine acceptability.
format Online
Article
Text
id pubmed-10090037
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100900372023-04-13 Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study Storph, Rebecca Peniel Essuman, Mainprice Akuoko Duku‐Takyi, Ruth Akotua, Albert Asante, Samuel Armah, Richard Donkoh, Irene Esi Addo, Prince Anim Health Sci Rep Original Research BACKGROUND AND AIM: The COVID‐19 booster dose has been cited as an important supplement for the control of the COVID‐19 pandemic due to reports of waning immunity among fully vaccinated persons. Determining factors that would affect its acceptability is necessary for initiating successful vaccination programs. In this study, we aimed to evaluate the factors associated with the acceptability of the COVID‐19 booster dose in Ghana. METHODS: We conducted an online cross‐sectional survey among the public. A self‐administered questionnaire was used to collect information on demographic characteristics, willingness to vaccinate, perceptions toward COVID‐19 vaccines, and trust in the government. Participants provided reasons and sources of advice that may affect their willingness to accept a booster dose. Using IBM SPSS and R Statistic; descriptive, univariate, and multivariate analyses were performed. RESULTS: Out of 812 respondents, 375 (46.2%) intended to accept the booster dose. Individuals who were males (adjusted odds ratio [aOR] 1.63, 95% confidence interval [CI] 1.07−2.48), had previously received other forms of vaccination twice (aOR 1.96, 95% CI 1.07−3.57) or in most years (aOR 2.51, 95% CI 1.38−4.57), tested positive for COVID‐19 (aOR 3.46, 95% CI 1.23−10.52), have high trust in government (aOR=1.77, 95% CI: 1.15‐2.74) and had positive perceptions regarding COVID‐19 vaccines (OR = 14.24, 95% CI: 9.28−22.44) were more likely to accept a booster dose. Experiencing side effects from the primer dose (aOR 0.12, 95% CI 0.08−0.18) was associated with reduced acceptance. Concerns about vaccine safety and efficacy were the common reasons impeding willingness, while advice from health professionals would be the most considered. CONCLUSION: Low intention to accept the booster dose which is associated with a range of factors including the perception of vaccines and trust in the government, is a cause for concern. Thus, more effort would have to be taken through education and policy interventions to increase booster vaccine acceptability. John Wiley and Sons Inc. 2023-04-11 /pmc/articles/PMC10090037/ /pubmed/37064312 http://dx.doi.org/10.1002/hsr2.1203 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Storph, Rebecca Peniel
Essuman, Mainprice Akuoko
Duku‐Takyi, Ruth
Akotua, Albert
Asante, Samuel
Armah, Richard
Donkoh, Irene Esi
Addo, Prince Anim
Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study
title Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study
title_full Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study
title_fullStr Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study
title_full_unstemmed Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study
title_short Willingness to receive COVID‐19 booster dose and its associated factors in Ghana: A cross‐sectional study
title_sort willingness to receive covid‐19 booster dose and its associated factors in ghana: a cross‐sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090037/
https://www.ncbi.nlm.nih.gov/pubmed/37064312
http://dx.doi.org/10.1002/hsr2.1203
work_keys_str_mv AT storphrebeccapeniel willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT essumanmainpriceakuoko willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT dukutakyiruth willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT akotuaalbert willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT asantesamuel willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT armahrichard willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT donkohireneesi willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy
AT addoprinceanim willingnesstoreceivecovid19boosterdoseanditsassociatedfactorsinghanaacrosssectionalstudy